Åsa Petersén
41 – 50 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.
(
- Contribution to journal › Article
-
Mark
Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study.
(
- Contribution to journal › Letter
-
Mark
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
(
- Contribution to journal › Article
-
Mark
Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.
(
- Contribution to journal › Article
- 2014
-
Mark
Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease.
(
- Contribution to journal › Article
-
Mark
Twisting mice move the dystonia field forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α
(
- Contribution to journal › Article
- 2013
-
Mark
Maintenance of Basal Levels of Autophagy in Huntington's Disease Mouse Models Displaying Metabolic Dysfunction.
(
- Contribution to journal › Article
-
Mark
Ethical aspects of undergoing a predictive genetic testing for Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
(
- Contribution to journal › Article